Member Info for MR.Spacetomato

Joepo3, good idea. We can change the title and respond, maybe?

ali_maynard1982, ok, ok, I heard it..ncyt has a good product and you will dominate the PCR markets..and obliterate your enemies!

Unfortunately, for you, I am not interested in your product. Why don't you try the guys next door? My wife told me they might be interested in your line of products? They are the ODX hillbillies clan. Now and then they shoot at us some of their antibody tests...they fall short. You may be able to sell your PCR kits to them.

Good luck... clank (the sound of the door closing)

Kayjay66,

And do you know why none of them walk out? For the same point you mention regarding Nike, Adidas and many others. They are all made in 3rd world countries. You lift the lid on one and it will be a pandora's box.

And B to Z so called celebrities will sell their mum's secrets for 15 min of fame.

Did you stop buying on Primark's after the slave stories? I still buy my t-shirts to sleep and my socks there. They told me they addressed the issues and that's good for me.

Good day, Inferno! Sorry, that felt funny just to say it.

Anyway, you asked a few questions, so I will give my answers (not that anyone would give a rat's behind..).

"So what’s people’s buy price this week "?
Well, for my wife, she bought all her SIPP and ISA (I know ,I know) at 268, 277 and 288.

"The weekend talk on this board has been of the Friday sell off with a view to buying back in".
Too late, already in! The drop was like a "flash sale at Tesco's"...by the time it happens all you hear is the sound of "piranhas rush" in the water, and by the time you get go the damn aisle all the discounted items are GONE!

"..Or are you going to watch it tank and buy in at exactly the right moment when it touches the floor before rising like the ashes to maximise your profit"s? 
Mooohuhuhahaha! You are kidding, right? The funds are not selling this time, because some regurgitated news? Did you see Booboo on TV news this weekend, talking about for ages that regurgitated story? No? Ooh!!
What about every single paper? Financial Times? No? Are you sure? Ohh!

Tomorrow, we will see nothing. And the day after, nothing. And the whole of next week, nothing. And the share? I leave that to you to try and guess.

Those shorters make money on the way down as they do on the way up. They hedge them. The only losers are us when we follow the stampede towards the exit door, when someone drops a stinker.

Fundamentals and BoD firm actions will guide our my family investments. The high street is quiet; people cannot ho abroad to spend money on holidays; they stay in front of a computer or tablet buying lovely clothes to go out in the uk.

Come September and the next few months.

Chengdo, I get that. But my point was the different approach to their tests. :0)

I am sorry to hear about your mum's passing, GAZALA69. I have been there, as have, unfortunately, many others on this board who have lost, or have family being touched by cancer some way or another.

For those going through it I wish all the best with their fight.

G.

RegulatorUK,

Mologic didn't post a word promoting their antigen tests with their partners as they have done with the antibody? Why?

Surely they must have been working on it at least for the same length avacta has? Yet, they haven't published a word on their analytical evaluation results, or at least mention that they have done it? They did that for the antibody test on their website, and on a previous paper:

https://www.medrxiv.org/content/medrxiv/early/2020/05/05/2020.04.29.20082099.full.pdf

I did some digging I the Institute Pasteur de Dakar, but no luck. They talk about antigen but no clinical studies.

That's why I find it strange that Mologic is not as open about their antigen results, or at least their stages of development, as they have been in respect to the Heathrow trials? Hence an attempt to get in through a back door?

Excuse me, just one more thing... Mologic has been trumping up their trials with their antibody and the collaboration with LSTM, but has not done the same with their antigen, why?

Hello, LiS.

I don't think generalizing "a lot of investors are in denial" based by a couple of posters here is a fair comment.

What I know is that Mologic, with their antigen test, doesn't seem to have made into the Condor Clinical by the front door. The companies who have have been mentioned by the government.

This Heathrow trial is for some here a combination of PR show to shareholders, a poke at the government to do something, a study on how things will work at the airport in terms of passengers flow logistics (pregnancy/holographic/PCR type machine - shall passenger do the test pre check-in, before or after immigration..etc) and then, the clinical trial results, by the airport, will be given to a sub group from Condor to look at.

If you look at the news in America about the Abbot test kit...it is been shot down...by CNN and others, not to mention by academics...the kit, as you know is for symptomatic cases only. So, I don't think most here are worried about sharing our potential market with competitors...but so far, unless it is an antigen machine tester kit, only Mologic would seem to have something to match ours, yet, unlike ours, they are not even mentioned by the government and one can find very little on their progress in the antigen field, unlike avacta.

So, I think most here are not too concerned after our immensely researched AVCT. We lifted every bloody stone, we all asked "...just one more thing" ..whilst holding a cigar between our fingers, so I don't think we most will panic in the last few yards of the finishing line.

Doh, I would keep my distance from the Odx tribe if I wore you.. You poke one of them in the eye with one of their antibody tests, they will rush to drink some magic potion for strength and then they bring the whole family over here...Obelix, Dogmatix, Getafix, Cacofonix and God damn Geriatrix to try and have a battle of wits with you.

Wilson

It is illogic that Mologic will have to, via an airport trials, to give their clinical results to a sub-group that belongs to the Main Body of Experts in the CONDOR group of scientists.

Good night everyone.

Ok, people, whist I was having some porridge with Wilson, I remembered something, so I had to return and post, although I said we would meet on Tuesday 07:01. It is about that point I asked myself...why Moilogic is going on the sideline on some airport trial and are not mentioned on the CONDOR clinical programme? Well, because in my view they didn't manage to join the selection process:

"Accessing CONDOR

Manufacturers who have new diagnostic tests (and other testing material) should complete the relevant testing webform on gov.uk.

These offers are then triaged through expert validation panels. Diagnostic tests that meet the requirements of the validation panels are passed to CONDOR for evaluation".

Sorry, no more antibody tests, please: https://consultations.dhsc.gov.uk/Full-Test-Kit-Covid19

Are you what we are looking for? https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/coronavirus-covid-19-serology-and-viral-detection-testing-uk-procurement-overview

Initial review of offers (triage)

For viral detection tests, the online form submissions are reviewed and triaged by the clinical and diagnostic experts at the Viral Detection Tests Advisory Group (VTAG), which meets once a week.

Triage is based on a review of the clinical and technical information provided against the MHRA TPP(s) and consideration of the commercial information provided.

At triage, tests are deemed:

aligned to our current national testing priority needs and progressed for national assessment and evaluationnot aligned to our current national testing priority needs and held on file for review in case of any future changes to our testing needsto currently not have the clinical data required to pass triage but where we recommend that the organisation generates this data

Companies are notified by the VTAG whether their product will progress to national evaluation or if it will be held on file for future reference within 7 working days".

Did Moilogic not pass the triage? Hmmm

ST

Hello People,

I had a look at BOO again as my wife loves the shares and wanted to get them this last Friday. I advised her to buy EZJ instead, though I agree with her BOO is a short, medium and long term great stock, and despite the "regurgitated" story by lame freelancers BOO is doing everything a reputable company has to do to put things right, including trying to protect the jobs of those who work for the suppliers (admirable) as well as creating more jobs, during a crisis, with their new factory.

Although she wasn't too happy, I explained to her that I expect EZJ to do well on the news of rapid antigen tests at airports to launch soon. She was reluctant but agreed, with the agreement that if it didn't she would sell it and buy BOO.

I cannot tell you how lucky that move was. Having said that, seeing BOO dropping to 295p, after I received a warning bell from a friend, both the wife and I jumped on the tablets to sell EZJ and have the cash ready to buy BOO, and load her SIPP and ISA with her favourite stock. It felt like those guys we saw on TV buying stacks of toilet rolls before everyone else found out they ran out of stock...silly I know. We got in at 268, 277 and 288.5. She burped after we finished buying so glad she was. Damn, she doesn't even care if they drop on Tuesday.

Now, I find it too coincidental ODI opened a short on the 21st and we get this regurgitated article on a Friday, just before market close, and not after 16:30, don't you think? Nevermind, she thanks the Guardian for the opportunity.

Why I don't believe we shall see the same massive drop BOO had last time? Because every Tom, Dick and Harry knows the work BOO is doing to clear the mess. Everyone knows the Guardian has nothing but regurgitated news. No Funds will sell BOO shares anymore as they are in now to make money; the Funds that wanted out are out. What we saw last Friday was the wilder beasts stampede if someone shouts... "LION"!

One only needs to look at the volume/time frame/chart comparison between friday and the last major drop when the funds left. Look at the volume and the disproportionate drop in the price on a continuous trend.

Ok, tomorrow we may get another repeat article on the Sunday Times, as they probably ran out of tragic stories to sell a few copies so, maybe let's regurgitate once more the regurgitated lumps of already regurgitated boo story...mooooooo they say.

By Monday we are already bored, and by Tuesday I cannot even remember what I had for breakfast! I only remember one thing...my wife is happy.

Bring on sales results and the new factory opening (I bet you that will not be posted on the Guardian- new jobs created by boo - as well not please the ODI guys)!
ST

I

Spike, I found a paper from them on the antibody studies back in march, where they referenced the antigen work, but no specific studies on the antigen. Back then they reached 88% sensitivity on the antibody, which clearly they have improved as per what we see in Mologic's website.

Well, Avacta is conducting the clinical validation and so appears to be Mologic. What strikes me is that Mologic, despite their pseudo advanced stage, has not, as it seems, been included in the main Condor studies to vouch for them to appear in UK gov website. IE, whatever Heathrow Airports bosses report on their findings, it will go to a sub-group of academics who have been working on the main Condor clinical studies, where Avacta is.

I wonder why Mologic was not included in the Condor programme? I am sure they would not miss that opportunity to write it on their website to promote their product!

I will again repeat my view that what is on the papers today, about the Heathrow trials, appears to be an effort to propel the government to open open the skies and, as others mentioned here, to appease the Heathrow group shareholders and the airlines that something is being done. We may see the airline shares going up on Tuesday I guess.

See you all at 07:01 on Tuesday.

ST

Spike, the LSTM is partnered with Mologic and I wonder where the clinical results are? It is under raps in this case, uless we find it somewhere with the institut Pasteur in Dakar?

What strikes me also is that, despite everything I tried to dig on the Mologic Antigen Test I cannot find any reference to it sensitivity or specificity on their clinical trials with LSTM. And as I referred earlier, whether it can be used for asymptomatic cases? I can only assume it can as per Heathrow trials.

SONA did disclose the sensitivity data on theirs post clinical and even the analytical results. Mologic is not in the aim, so there is no market sensitive news to be feared here.

Ok, so it is now almost certain to me that the airport testing trials are an independent approach from Heathrow Airport authorities to try these 3 kits in order to push the government into opening the skies. They do not form part of the structure created under the Condor studies with certain successfully selected companies, Avacta being one, to find rapid and effective tests. However, the results will be shared later with the Condor programme in order to evaluate these trials with a bigger trial.

I found this on:

https://www.moodiedavittreport.com/heathrow-to-share-covid-19-testing-data-to-help-revive-travel/

An extract:

"Colleagues were given the option to choose which of the solutions they trialled. However, as the results of these initial trials are only advisory until the methodologies are proven to work in a non-clinical setting, participating colleagues also took a Government-approved, privately provided PCR test, administered by Collinson Assistance Services Ltd. to compare their results to Government-accredited tests.
Earlier this month, the Government unveiled plans to trial new rapid coronavirus tests across NHS hospitals, care homes and labs to understand how these alternative methods could help to increase testing capacity in preparation for winter.

Heathrow’s own trials will feed into the Government’s findings after being independently evaluated by a subgroup of academics that are part of CONDOR. It is hoped that these findings will then be used to support the recovery across sectors.

CONDOR is working to accelerate the real-world use of COVID-19 diagnostics and their findings will help to identify the most accurate testing methods. Results of the study are being sent to the Department for Health and Social Care to support the decision making process".

ST

No worries Canute, apologies where it is deserved.

ST

Sorry HarriM. I take that back. I will jog on on this one. I misread what you said indeed.

ST

HarriM, apart from the antibody test, great for data analysis, they haven't got a CE marking.

As per Avacta, we not only are included in the Condor studies and highlighted in the UK gov website, our CE marking for our Antigen test we know the following:

"... In parallel with these clinical validation studies, which will be run within the UK government’s CONDOR programme and potentially with other collaborators globally, BBI will work with Avacta and Cytiva to produce the additional technical documentation that is required for CE marking of the final product".

Our CEO says the following:

"The diagnostics business has also been working at a rapid pace towards ISO13485 accreditation, which will streamline CE marking and other regulatory approval processes".

From RNS on the 06 Aug 2020
COVID-19 Rapid Antigen Test Manufacturing Partner

So, in short, you need to do better than that if you want people here to put down their cup of tea in order to read you unreferenced statements.

Jog on.

ST